U.S. Reaches $2.1 Billion Deal With Sanofi, GlaxoSmithKline For COVID-19 Vaccine Push

By Sydney Lupkin

Published July 31, 2020 at 10:02 AM MDT

This is the sixth vaccine candidate to join Operation Warp Speed's portfolio, and the largest vaccine deal to date.

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR.